Abstract

Venous thromboembolism (VTE) associated with surgery can cause serious comorbidities or death and imposes a substantial economic burden to society. The study examined VTE cases after surgery to determined how this condition imposed an economic burden on patients based on the national health insurance reimbursement database. Methods: This retrospective analysis adopted the public payer's perspective. The direct medical cost was estimated using data from the national claims database of Vietnam from Jan 1, 2017 to Sep 31, 2018. Adult patients who underwent surgeries were recruited for the study. Patients with a diagnostic code of up to 90 days after surgery were considered VTE cases with the outcome measure being the surgery-related costs within 90 days. The 90-day cost of VTE patients was found to be US$2,939. The rate of readmission increased by 5.4 times, the rate of outpatient visits increased by 1.8 times and total costs over 90 days in patients with VTE undergoing surgery increased by 2.2 times. Estimation using propensity score matching method showed that an increase of US$1,019 in the 90-day cost of VTE patients. The VTE-related costs can be used to assess the potential economic benefit and cost-savings from prevention efforts.

Highlights

  • Venous thromboembolism (VTE) is with the formation of blood clots that starts in the vein and may lead to long-term comorbidities or death [1], resulting in a significant economic burden on healthcare systems

  • The rate of readmission increased by 5.4 times, the rate of outpatient visits increased by 1.8 times and total costs over 90 days in patients with VTE undergoing surgery increased by 2.2 times

  • Estimation using propensity score matching method showed that an increase of US dollar (US$)1,019 in the 90day cost of VTE patients

Read more

Summary

Introduction

Venous thromboembolism (VTE) is with the formation of blood clots that starts in the vein and may lead to long-term comorbidities or death [1], resulting in a significant economic burden on healthcare systems. With an estimated annual incidence of approximately 5–20 out of 10,000 persons [2,3,4], VTE is considered a common disorder. Out of 173 patients who had large open laparoscopic surgery, up to 24.3% were VTE cases [8]. Venous thromboembolism (VTE) associated with surgery can cause serious comorbidities or death and imposes a substantial economic burden to society. The study examined VTE cases after surgery to determined how this condition imposed an economic burden on patients based on the national health insurance reimbursement database. Patients with a diagnostic code of up to 90 days after surgery were considered VTE cases with the outcome measure being the surgery-related costs within 90 days

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call